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Abstract
Sickle cell anemia (SCA) is the commonest hemoglobin disorder among the black 
population worldwide. Children with SCA may eventually end up with end-organ 
complications: the kidneys being one of the most frequently affected organs. The 
renal complications arise from medullary ischemia and infarction leading to features 
of tubular dysfunction such as hyposthenuria and renal tubular acidosis. Early in life, 
children with SCA may present with hyposthenuria: one of the earliest renal defects 
in the disease which results in an obligatory urine output of more than 2 l in a day. 
The symptomatic manifestation as nocturnal polyuria is thought to be the reason for 
nocturnal enuresis observed in these children. In spite of the more prevalent occur-
rence of nocturnal enuresis in children with SCA than in their non-SCA colleagues, 
its precise underlying mechanisms still remain controversial, with divergent conclu-
sions regarding its pathogenesis. However, the consensus is now tilting towards a 
multifactorial etiopathogenesis in affected children. This book chapter aims to discuss 
the epidemiologic perspectives of nocturnal enuresis in SCA, as well as the current 
hypotheses on the etiopathogenesis of this complication.
Keywords: sickle cell anemia, nocturnal enuresis, hyposthenuria,  
multifactorial etiopathogenesis
1. Introduction
Sickle cell anemia (SCA) is the commonest hemoglobin disorder among 
the black population worldwide [1, 2]. As a genetic defect with the Mendelian 
autosomal-recessive inheritance, children with the sickle cell hemoglobin genes 
in the homozygous form have reversibly sickled and irreversibly sickled red blood 
cells. These abnormal red cells, which become rigid having lost their deformability, 
consequently block the microvasculature resulting in vasoocclusion. They are also 
prone to damage which leads to chronic hemolysis. Most of the clinical features of 
SCA are essentially related to these two events.
Children with SCA may eventually end up with end-organ complications: the 
kidneys being one of the most frequently affected organs. The renal complications 
arise from medullary ischemia and infarction leading to features of tubular dys-
function such as hyposthenuria and renal tubular acidosis [3]. As early as 3 years of 
age, children with SCA may present with hyposthenuria: one of the earliest renal 
defects in the disease which results in an obligatory urine output of more than 2 l 
in a day [4]. The symptomatic manifestation as nocturnal polyuria is thought to 
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be the reason for the observed nocturnal enuresis in these children. In spite of the 
more prevalent occurrence of nocturnal enuresis in children with SCA than in their 
normal colleagues, the precise underlying mechanisms have not yet been resolved. 
Research on the subject has led to divergent conclusions about the pathogenesis; 
one report had earlier suggested that hyposthenuria was a major determinant of 
enuresis in the disease [5], while other authors not only controverted this observa-
tion but had reported disparate etiopathogenic factors [6–8]. In fact, a recent review 
of published evidence on the subject indicates similar determinants of nocturnal 
enuresis for both SCA and non-SCA patients [9]. Thus, the role of hyposthenuria 
as the exclusive determinant of nocturnal enuresis in children with SCA remains 
debatable although the consensus is now tilting towards a multifactorial etiopatho-
genesis in affected children.
This book chapter aims to discuss the epidemiologic perspectives of nocturnal 
enuresis in SCA, as well as the current hypotheses on the etiopathogenesis of this 
complication.
2. Nocturnal enuresis in SCA: epidemiologic perspectives
Nocturnal enuresis has been defined as the persistence of urination in the bed 
(bedwetting) at night, two or more times per week after the age of 5 years, for 
a period of at least 3 months [10]. It can present as a primary form (no previous 
dry period) or a secondary form (previous dry period), and as monosymptomatic 
(absence of daytime symptoms) or non-monosymptomatic (presence of daytime 
symptoms) [9]. Studies which show that children with SCA have a tendency for 
nocturnal enuresis more than children with normal hemoglobin however reported 
different prevalence rates and epidemiologic patterns, depending on study methods 
and definition criteria (Table 1).
2.1 Presumed risk factors for nocturnal enuresis
For instance, the possible effect of sex and socioeconomic status on enuresis in 
children has been well documented in several studies [7, 11–16]. Firstly, male pre-
dominance was noted among children with SCA in some of the studies [7, 11, 13–15], 
whereas a female predominance was reported in one study [12]. Although the disparity 
could be due to study selection bias, a similar trend of male predominance has also 
been reported among non-SCA children [15, 17]. This gender bias suggests that con-
tributory factors to nocturnal enuresis in non-SCA children such as slower maturation 
and reduced responsiveness to toilet training in boys [18], and more frequent devel-
opmental delays [19], may also apply to children with SCA. Secondly, there appears 
to be no significant impact of socioeconomic status on the prevalence of nocturnal 
enuresis in both SCA children [7, 14], and their non-SCA counterparts [16]. However, 
a previous report indicates that enuresis in non-SCA children was more frequent in 
those from lower socioeconomic classes [17], whereas another study noted a higher 
prevalence among non-SCA children from higher socioeconomic classes [20].
2.2 Global prevalence rates of nocturnal enuresis
There is a wide variation in the global prevalence rates of nocturnal enuresis 
among children with SCA (Table 1). Prevalence rates vary from 25–51% depending 
on methodology and definition of nocturnal enuresis adopted in each study. In the 
West African sub-region, prevalence rates of 41.6, 31.4 and 47.1% were reported in 
south-west [11], south-east [14], and north-west [15] regions of Nigeria respectively. 
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Study 
authors 
(Country)
Study method 
(age bracket)
NE definition Prevalence 
rates (N)
Sex 
predominance
Effect of 
socioeconomic 
status
Eneh et al. 
(Nigeria)†
Prospective 
parental 
interview 
(5–11 years)
DSM-IV criteria 31.4% (70) Male Not significant
Akinyanju 
et al. 
(Nigeria)‡
Prospective 
parental 
interview 
(4–20 years)
Involuntary 
passage of urine 
during sleep>1/
month
41.6% (209) Male Not reported
Ogunrinde 
et al. 
(Nigeria)††
Prospective 
parental 
interview 
(5–16 years)
≥3 bedwetting 
episodes/ 
month 
(5–6 year old) 
or 1 episode/
month (>6 year 
old)
47.1% (360) Male Not significant
Mabiala 
Babela et al. 
(Congo 
Brazzaville)
Cross-
sectional study 
(5–20 years)
Micturition 
during sleep 
in a child aged 
>5 years
51% (456) Female Not reported
Portocarrero 
et al. (Brazil)
Prospective 
questionnaire 
(5–17 years)
Not stated 32% (155) Not reported Not reported
Barakat et al. 
(USA)
Prospective 
phone 
interview 
(5–22 years)
Nocturnal 
urinary 
incontinence 
>5 years of age 
(>2/week for 
3 months)
39.2% (217) Male Not reported
Jordan et al. 
(USA)
Prospective 
interview 
(5–17 years)
Urinary 
incontinence 
>5 years of age 
(>2/week for 
3 months)
25% (126) Not reported Not reported
Figueroa et al. 
(USA)
Prospective 
screening 
questionnaire 
(6–21 years)
Bed wetting at 
least 2/week
30% (91) Not reported Not reported
Field et al. 
(USA)
Prospective 
questionnaire 
(6–20 years)
Recurrent bed 
wetting
33% (213) Not reported Not reported
Lehmann 
et al. (USA)
Prospective 
questionnaire 
(4–19 years)
Pre-sleep bed 
wetting/month
39% (221) Not reported Not reported
Readett et al. 
(Jamaica)
Prospective 
interview 
(8 years)
Bed wetting 2 
nights/week
45% (175) Male Not significant
Ekinҫi et al. 
(Turkey)
Prospective 
questionnaire 
(6–40 years)
Bed wetting at 
night >1/week 
for 3 months
26.4% (55) Not reported Not reported
N = study population, DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, 
USA = United States of America.†South East Nigeria.
‡South West Nigeria.
††North West Nigeria.
Table 1. 
Nocturnal enuresis (NE) in children with sickle cell anemia: epidemiologic perspectives.
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The study in south-east of the country prospectively interviewed parents of SCA 
subjects aged 5–11 years and parents of age- and sex-matched non-SCA controls; using 
the Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) 
criteria to define nocturnal enuresis [14]. In South West Nigeria, the authors also 
used prospective parental interview for subjects and controls aged 4–20 years, but 
defined nocturnal enuresis as ‘involuntary micturition during sleep which occurred 
more often than once in a month’ [11]. Conversely, the study in North West Nigeria 
used a structured questionnaire to obtain information from parents of enrolled 5- to 
16-year-old subjects and controls; defining nocturnal enuresis as ‘3 or more episodes of 
bedwetting per month in a child aged 5 to 6 years and at least, once monthly in an older 
child’ [15]. In Central Africa, a prevalence rate of 51% was reported in a cross-sectional 
study of 5- to 20-year-old SCA patients (with age- and sex-matched controls) in 
Congo-Brazzaville which used the defining criteria for nocturnal enuresis as ‘complete 
act of urination most often during sleep in a child over 5 years’ [12]. Elsewhere in 
South America, a Brazilian study which was conducted on 5- to 17-year-old Negroid 
children and adolescents with SCA reported a prevalence rate of 32% [21]. The authors 
prospectively administered a questionnaire on the caregivers of these subjects and 
their age-matched controls. In North America, studies in the United States conducted 
among African-Americans documented prevalence rates of 39% [6], 39.2% [13], 
25% [22], 30% [23], and 33% [24]. In these studies, there was disparity in the age 
bracket of the study population and the definition adopted for nocturnal enuresis. A 
prospective phone interview was used in one study, which defined nocturnal enuresis 
as ‘incontinence of urine at night after 5 years of age, more than twice a week for at 
least 3 months,’ while the study population were aged 5–22 years [13]. Another study 
employed a prospective interview of parents whose children were aged 5–17 years, and 
defined nocturnal enuresis as ‘incontinence of urine at night after 5 years of age, more 
than twice a week for at least 3 months’ [22]. Two of the studies utilized prospective 
questionnaires [6, 24], but interviewed primary caregivers of subjects who were aged 
6–20 years [6], and 4–19 years [24]; defining nocturnal enuresis as ‘recurrent problem 
with bedwetting’ [6], and ‘wet bed in 1 month before sleep study’ [24]. In the last of 
the studies, nocturnal enuresis was defined ‘as wetting bed at least twice per week’ 
[23]; primary nocturnal enuresis was studied among subjects aged 6–21 years with a 
prospective screening questionnaire. In the Caribbean, a Jamaican study which used 
the prospective interview method reported a prevalence rate of 45% among 8-year-old 
SCA patients [7]. The authors’ definition of nocturnal enuresis was ‘being wet for at 
least 2 nights per week.’ A study in Turkey which adopted the definition criterion of 
nocturnal enuresis as ‘wet bed at night more than once a week for at least 3 months,’ 
reported a prevalence rate of 26.4% [25]. The investigators conducted semi-structured 
interviews with caregivers of pediatric and adult patients. Perhaps, the combination 
of SCA and thalassemia patients in the study population (with preponderance of the 
latter) as well as the wide age-bracket of 6–40 years accounted for this comparatively 
lower prevalence rate. Furthermore, it has been established that the prevalence of 
nocturnal enuresis decreases with advancing age, although this finding was essentially 
noted among non-SCA subjects [26, 27].
3. Nocturnal enuresis in SCA: hypotheses on etiopathogenesis
There are now several hypotheses on the etiopathogenesis of enuresis in children 
[9, 28, 29]. In fact, it is believed that children with SCA may have a tendency to 
develop nocturnal enuresis because of the common general etiopathogenic fac-
tors in childhood, SCA-related etiopathogenic factors or a combination of both 
[9]. Specifically, the unresolved questions include the following: What is the exact 
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role of hyposthenuria in SCA-related nocturnal enuresis? What are the contribu-
tory bladder-specific factors? Is there any relationship between sleep disordered 
breathing (SDB) and nocturnal enuresis in SCA? and Is there a difference in arous-
ability threshold in normal subjects with nocturnal enuresis and those with SCA? 
[9]. Interestingly, the current hypotheses on the etiopathogenesis of SCA-related 
nocturnal enuresis revolve around these posers.
Firstly, the nocturnal polyuria resulting from hyposthenuria has long been 
suggested as the cause of nocturnal enuresis in SCA patients [5]. This hypothesis 
is supported by the fact that hyposthenuria is one of the commonest and earliest 
infarction-related renal complications, as intravascular sickling occurs more readily in 
the kidneys than in any other organs [30]. The microvasculature of the renal medulla 
is particularly susceptible to hypoxia induced by sickling and vasoocclusion [31]. 
Medullary ischemia and infarction result in the impairment of the urine-concentrating 
ability of the vasa recta and juxtamedullary nephrons, as failure of this function is 
thought to manifest as polyuria and enuresis [32, 33]. Although the ‘hyposthenuria 
hypothesis’ has been disputed by some authors who failed to establish a causal link 
between SCA and enuresis [7, 34], it has later been observed that both urine osmolal-
ity and overnight urine volume after fluid restriction were similar in enuretic and 
non-enuretic children with SCA; making the authors to conclude that low maximum 
functional bladder capacity and high overnight urine volume to maximum functional 
bladder capacity ratio were the determinants of nocturnal enuresis in affected children 
rather than low urine osmolality and high overnight urine volume [8].
Secondly, another hypothesis on nocturnal enuresis in the general population is 
that it results from an interaction of detrusor instability, delayed arousal from sleep 
and nocturnal polyuria [28]. Other authors also observed that in enuretic children, 
the nocturnal bladder capacity during sleep was significantly smaller than the 
diurnal functional capacity; thus highlighting the role of the inability to hold urine 
during sleep as an important etiopathogenic mechanism for nocturnal enuresis [29]. 
Nocturnal polyuria, nocturnal detrusor over-activity and high arousal thresholds 
are now regarded as crucial factors in the pathogenesis of enuresis, with an under-
lying mechanism on the brainstem level probably common to these pathogenic 
mechanisms [35]. In a review which appraised the possible etiopathogenic factors of 
primary nocturnal enuresis, the partly proven mechanisms were listed as matura-
tional delay of the central nervous system, genetic factors, sleep disorders and SDB, 
and low levels of nocturnal anti-diuretic hormone (ADH) secretion [36]. Among 
these hypotheses, delayed functional maturation of the central nervous system is 
thought to be the most plausible mechanism for nocturnal enuresis as it reduces the 
child’s ability to inhibit nocturnal bladder emptying [36]. This theory is supported 
by the observation of spontaneous improvement in enuresis which occurs with 
advancing age [26]. Despite bladder filling, the non-perception of the sensory out-
put emanating from its stretching removes the cortical control on the contraction 
of the urethral sphincter. Failure of the sleep arousal mechanism due to high arousal 
thresholds may also contribute to this inability to inhibit nocturnal bladder empty-
ing. Presumably, these hypotheses on etiopathogenesis also apply to nocturnal 
enuresis in children with SCA. For instance, in these children a strong link between 
nocturnal enuresis and urinary bladder dysfunction has been reported by several 
authors [8, 37, 38]. Another recent postulation is that SCA-related enuresis may be 
due to atonic detrusor muscle which results in an underactive bladder with defective 
emptying mechanism. This abnormality is thought to be a consequence of chronic 
bladder ischemia caused by recurrent cycles of ischemia-perfusion injury triggered 
by vasoocclusion [39]. Evidence for this hypothesis was reported by some authors 
who studied the urinary bladder function in a transgenic sickle cell disease murine 
model and found these pathophysiologic changes: reduced urine output, inability 
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to produce the typical bladder contraction and emptying, lower detrusor muscle, 
small bladder contraction and reduced urethral contraction [40].
Thirdly, the role of sleep disorders and SDB in the etiopathogenesis of nocturnal 
enuresis has also been advanced as a sleep-related study show that patients with noc-
turnal enuresis have difficulties in waking, and are thus considered as ‘deep sleepers’ 
[41]. In addition, nocturnal enuresis is associated with SDB as a result of upper airway 
obstruction in children; surgical relief by tonsillectomy, adenoidectomy or both was 
reported to have reduced nocturnal enuresis in up to 76% of patients [42]. In a recent 
study, enuresis has not only been linked to SDB in children with SCA but the severity 
of SDB has been observed to have a strong correlation with frequency of nocturnal 
enuresis [6]. Notably, SDB is a common sleep disorder comprising a spectrum from 
snoring to obstructive sleep apnea syndrome (OSAS) which may worsen nocturnal 
enuresis through disrupted sleep and neurologic dysregulation [9]. While the finding 
of a study suggests that SDB is more prevalent in children with SCA than in the general 
population [43], overwhelming evidence also shows that a significant relationship 
exists between SDB and nocturnal enuresis among non-SCA children [44–46].
Furthermore, the role of low levels of some vitamins in the etiopathogenesis of 
nocturnal enuresis has been highlighted in recent studies. For instance, enuretic 
children were observed to have lower serum vitamin B12 and folate levels than 
their non-enuretic counterparts [47, 48]. The reduced vitamin levels are believed 
to be associated with slow cortical maturation which has been linked to enuresis. 
Interestingly, significantly lower or deficient vitamin B12 levels have equally been 
reported in children with SCA compared to non-SCA controls [49, 50]. In addi-
tion, increased risk of nocturnal enuresis has been observed in vitamin D-deficient 
children as this vitamin deficiency directly correlated with severity of enuresis [51]. 
In a recent systematic review, the prevalence of vitamin D deficiency was reported 
to vary from 56.4% to 96.4% in children with SCA [52]. This link between vitamin 
D deficiency and nocturnal enuresis can be explained partly by its influence on SDB 
and nocturnal polyuria. Reports indicate that low level of serum 25 (OH) D was 
associated with increased risk of developing OSAS [53], as well as primary snoring 
[54]. The association of low vitamin levels with OSAS is reportedly mediated through 
promotion of adenotonsillar hypertrophy, chronic rhinitis and/or myopathy of 
airway muscle [55]. Better still, low vitamin D levels may result in nocturnal enuresis 
through obstructive sleep apnea, sleep fragmentation and nocturnal polyuria, which 
all occur in children with SCA [39].
Another etiologic consideration for nocturnal enuresis seen in SCA is its associa-
tion with some involuntary movements such as periodic limb movement syndrome 
and restless leg syndrome. The prevalence of periodic limb movement syndrome 
in SCA has been documented as 20.5–29% [56–58], which was significantly higher 
than the rates of 1.2–8% reported for non-SCA children [59, 60]. Similarly, a preva-
lence rate of 11.1% has been observed for children with restless leg syndrome [56]. 
Notably, both involuntary movements are associated with sleep disruption [60]. 
Given that enuretic children have higher incidence of periodic limb movement and 
sleep fragmentation [59] and the higher rate of periodic limb movement syndrome 
associated nocturnal enuresis and sleep disruption in SCA patients, it is therefore 
not surprising to observe a high prevalence rate of nocturnal enuresis in them. To 
underscore the nexus between these aforementioned etiologic factors (low serum 
vitamin D level and restless leg syndrome), it has been observed that Vitamin D 
supplementation also improved the severity of this involuntary movement [61].
In summary, the etiopathogenic mechanisms involved in nocturnal enuresis among 
SCA and non-SCA children are multifactorial and not mutually exclusive, and they 
include hyposthenuria-related nocturnal polyuria, decreased bladder capacity or 
nocturnal bladder over-activity, high sleep arousal thresholds and SDB [9] (Figure 1).
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4. Conclusion
Although nocturnal enuresis appears more prevalent in children with SCA than 
in their non-SCA counterparts, the exact etiopathogenesis of enuresis is not com-
pletely understood. In fact, the suggested mechanisms for nocturnal enuresis in SCA 
children are also applicable to their non-SCA counterparts. Moreover, the multire-
gional variations in prevalence rates may be due to differences in definition criteria 
and study methods. Male predominance in enuretic children has been somewhat 
established, but there is no unanimity yet on the influence of socioeconomic status 
on prevalence rates. Perhaps, adopting standardized definitions and study methods 
may in future minimize the disparities in the reported prevalence rates. More impor-
tantly, further research is still required to establish the precise etiopathogenesis of 
nocturnal enuresis in children with SCA.
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Figure 1. 
The proposed etiopathogenic mechanisms for nocturnal enuresis. SDB, sleep-disordered breathing; nocturnal 
polyuria, induced by hyposthenuria. Concept and design: by SNU (one of the authors).
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